{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-006979","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2023-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.045999+00:00","generated_at":"2026-06-18T08:14:05.473249+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oragenics appoints Janet Huffman as CFO effective March 7, 2023","bullets":["Janet Huffman named CFO, Secretary and Treasurer; base salary $250,000, target bonus 35%.","Granted 7,000 stock options at $4.00 exercise price under 2021 Equity Incentive Plan.","Options vest in five equal tranches over two years; severance includes 6 months salary if terminated without cause.","Huffman previously CFO of TRxADE HEALTH and Arboreta Healthcare; brings public company finance and M&A experience."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-006979","json":"https://secwatch.observer/filing/0001493152-23-006979.json","markdown":"https://secwatch.observer/filing/0001493152-23-006979.md","text":"https://secwatch.observer/filing/0001493152-23-006979.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223006979/0001493152-23-006979-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223006979/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T08:14:05.473249+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e185bb367c","claim":"Janet Huffman was appointed as Chief Financial Officer at ORAGENICS INC.","evidence_excerpt":"announced that the Board of Directors approved the appointment of Janet Huffman, as the Company’s new Chief Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223006979/0001493152-23-006979-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}